Opportunities

SAFE-PLASMA Protocol

Special Notice from Defense Health Agency (dha), solicitation HT9427-27-NOI-701. Responses due Nov 23, 2026. NAICS 541715. Listed on SAM.gov.

Solicitation
HT9427-27-NOI-701
Notice type
Special Notice
Department
Dept of Defense
Agency
Defense Health Agency (dha)
Office
Defense Health Agency (dha)
Posted
Nov 17, 2026
Responses due
Nov 23, 2026
Place of performance
Frederick, SD
Listed on
SAM.gov

Description

The Defense Health Agency Contracting Activity, on behalf of Portfolio Acquisition Executive for Medical Products, Warfighter Protection and Acute Care Project Management Office, intends to issue a contract modification on a sole-source basis with Westat Inc. 1600 Research Blvd. Rockville, MD 20850. This modification will enable Westat Inc. to modify the current clinical trial design to comply with FDA recommendations and to conduct the Good Clinical Practices (GCP) compliant clinical trial in accordance with U.S. Food and Drug Administration�s requirements for EZPLAZ� approval.

Loading the opportunity